Penny Stocks To Keep An Eye On – April 8th

60 Degrees Pharmaceuticals, Transocean, BigBear.ai, iQIYI, JetBlue Airways, ZyVersa Therapeutics, and Recursion Pharmaceuticals are the seven Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of small companies, often trading for less than a few dollars per share, which typically have limited liquidity and higher volatility compared to the stocks of larger firms. Because of their low price and market dynamics, they are considered high-risk investments, attracting speculative traders but also being susceptible to market manipulation and rapid price fluctuations. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

60 Degrees Pharmaceuticals (SXTP)

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue.

NASDAQ:SXTP traded up $1.27 during mid-day trading on Tuesday, reaching $3.07. The stock had a trading volume of 76,267,487 shares, compared to its average volume of 308,085. The business has a 50 day simple moving average of $2.31 and a 200 day simple moving average of $4.39. The firm has a market capitalization of $4.53 million, a price-to-earnings ratio of -0.30 and a beta of 3.41. 60 Degrees Pharmaceuticals has a twelve month low of $1.41 and a twelve month high of $35.99.

Transocean (RIG)

Transocean Ltd., together with its subsidiaries, provides offshore contract drilling services for oil and gas wells worldwide. It contracts mobile offshore drilling rigs, related equipment, and work crews to drill oil and gas wells. The company operates a fleet of mobile offshore drilling units, consisting of ultra-deepwater floaters and harsh environment floaters.

Shares of NYSE RIG traded down $0.17 during trading on Tuesday, reaching $2.21. The company had a trading volume of 60,596,863 shares, compared to its average volume of 23,168,802. The stock has a market capitalization of $1.95 billion, a PE ratio of -2.99, a price-to-earnings-growth ratio of 0.86 and a beta of 2.29. The company has a current ratio of 1.47, a quick ratio of 1.34 and a debt-to-equity ratio of 0.60. The stock has a 50-day moving average price of $3.27 and a two-hundred day moving average price of $3.83. Transocean has a twelve month low of $1.97 and a twelve month high of $6.88.

BigBear.ai (BBAI)

BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics, and predictive visualization solutions and services.

Shares of NYSE:BBAI traded down $0.24 during midday trading on Tuesday, reaching $2.70. The company’s stock had a trading volume of 43,308,663 shares, compared to its average volume of 23,224,970. The business has a 50 day moving average price of $4.95 and a 200 day moving average price of $3.40. BigBear.ai has a 1 year low of $1.17 and a 1 year high of $10.36. The firm has a market cap of $778.87 million, a price-to-earnings ratio of -2.96 and a beta of 3.34. The company has a quick ratio of 2.06, a current ratio of 2.06 and a debt-to-equity ratio of 2.08.

iQIYI (IQ)

iQIYI, Inc., together with its subsidiaries, provides online entertainment video services in the People's Republic of China. It offers various products and services, including online video, online games, online literature, animations, and other products. The company operates a platform that provides a collection of internet video content, such as professionally produced content licensed from professional content providers and self-produced content.

Shares of IQ traded down $0.20 during mid-day trading on Tuesday, reaching $1.55. The company had a trading volume of 65,199,634 shares, compared to its average volume of 32,444,443. The firm has a fifty day simple moving average of $2.26 and a 200-day simple moving average of $2.28. The stock has a market cap of $1.48 billion, a price-to-earnings ratio of 15.45, a price-to-earnings-growth ratio of 4.13 and a beta of -0.18. The company has a current ratio of 0.44, a quick ratio of 0.45 and a debt-to-equity ratio of 0.70. iQIYI has a fifty-two week low of $1.54 and a fifty-two week high of $5.80.

JetBlue Airways (JBLU)

JetBlue Airways Corporation provides air transportation services. The company operates a fleet of Airbus A321, Airbus A220, Airbus A321neo, Airbus A320 Restyled, Airbus A320, Airbus A321 with Mint, Airbus A321neo with Mint, Airbus A321neoLR with Mint, and Embraer E190 aircraft. It also serves 100 destinations across the United States, the Caribbean and Latin America, Canada, and Europe.

JetBlue Airways stock traded down $0.37 during trading on Tuesday, reaching $3.69. 26,710,510 shares of the company’s stock were exchanged, compared to its average volume of 24,489,160. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of -1.57 and a beta of 1.69. The company has a debt-to-equity ratio of 3.08, a quick ratio of 1.18 and a current ratio of 1.10. JetBlue Airways has a 52-week low of $3.61 and a 52-week high of $8.31. The company’s 50-day moving average is $5.99 and its two-hundred day moving average is $6.60.

ZyVersa Therapeutics (ZVSA)

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial to the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, IgA neuropathy, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity.

Shares of ZVSA traded up $0.30 during mid-day trading on Tuesday, reaching $0.88. 97,334,000 shares of the stock traded hands, compared to its average volume of 1,011,351. ZyVersa Therapeutics has a 12-month low of $0.55 and a 12-month high of $8.05. The stock has a fifty day simple moving average of $1.00 and a 200 day simple moving average of $1.37.

Recursion Pharmaceuticals (RXRX)

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers.

RXRX stock traded down $0.21 during midday trading on Tuesday, hitting $4.00. 18,354,889 shares of the company’s stock were exchanged, compared to its average volume of 11,124,896. Recursion Pharmaceuticals has a 12-month low of $3.80 and a 12-month high of $12.36. The company has a current ratio of 4.35, a quick ratio of 4.35 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $1.61 billion, a price-to-earnings ratio of -2.62 and a beta of 1.00. The firm has a 50 day moving average price of $7.17 and a 200-day moving average price of $6.93.